Countries citing papers authored by Luis G. Rodríguez
Since
Specialization
Citations
This map shows the geographic impact of Luis G. Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis G. Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis G. Rodríguez more than expected).
Fields of papers citing papers by Luis G. Rodríguez
This network shows the impact of papers produced by Luis G. Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis G. Rodríguez. The network helps show where Luis G. Rodríguez may publish in the future.
Co-authorship network of co-authors of Luis G. Rodríguez
This figure shows the co-authorship network connecting the top 25 collaborators of Luis G. Rodríguez.
A scholar is included among the top collaborators of Luis G. Rodríguez based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Luis G. Rodríguez. Luis G. Rodríguez is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Rodríguez, Luis G., et al.. (2015). Método de lente térmica resuelta en frecuencia para medir coeficientes de difusión térmica en muestras líquidas. Revista Mexicana de Física. 61(4). 301–306.1 indexed citations
Rodríguez, Luis G., et al.. (2014). Itolizumab humanized monoclonal antibody (anti-cd6) in patients with cd6+ lymphoproliferative disorders. Preliminary experience. Revista Cubana de Hematología, Inmunología y Hemoterapia. 30(3). 0–0.1 indexed citations
5.
Rodríguez, Luis G., et al.. (2013). Caracterización clínica y de laboratorio del mieloma múltiple en el Instituto de Hematología e Inmunología. SHILAP Revista de lepidopterología. 29(4). 382–397.
Rodríguez, Luis G., et al.. (2010). Rituximab: historia, farmacología y perspectivas. Revista Cubana de Hematología, Inmunología y Hemoterapia. 26(3). 186–197.
8.
Rodríguez, Luis G., et al.. (2010). Mieloma múltiple y embarazo: Primer reporte de caso en Cuba. Revista Cubana de Hematología, Inmunología y Hemoterapia. 26(1). 70–75.1 indexed citations
9.
Rodríguez, Luis G., et al.. (2010). Rituximab en leucemia linfocítica crónica en recaída y anemia hemolítica autoinmune. Presentación de un caso. Revista Cubana de Hematología, Inmunología y Hemoterapia. 26(2). 77–81.
10.
Rodríguez, Luis G., et al.. (2010). The multiple myeloma and the pregnancy: First case report in Cuba. Revista Cubana de Hematología, Inmunología y Hemoterapia. 26(1). 70–75.1 indexed citations
11.
Rodríguez, Luis G., et al.. (2010). Reacciones adversas del imatinib como droga de segunda línea en pacientes con leucemia mieloide crónica. Revista Cubana de Hematología, Inmunología y Hemoterapia. 26(3). 223–227.
Rodríguez, Luis G., et al.. (2006). Autoimmune manifestations in non-Hodgkin's lymphoma. Revista Cubana de Hematología, Inmunología y Hemoterapia. 22(1). 0–0.4 indexed citations
Rodríguez, Luis G., Xiaoyang Wu, & Jun‐Lin Guan. (2004). Wound-Healing Assay. Humana Press eBooks. 294. 23–30.487 indexed citations
17.
Rodríguez, Luis G., et al.. (2002). Empleo de la talidomida en una paciente con mieloma múltiple refractario. Revista Cubana de Hematología, Inmunología y Hemoterapia. 18(3). 0–0.1 indexed citations
Rodríguez, Luis G., et al.. (1993). [HLA A, B, C and DR antigens in a urban population from Santiago of Chile].. PubMed. 121(5). 523–9.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.